Last reviewed · How we verify
Impact of Syntrillo's Telehealth Service on Stroke Risk Factor Reduction in At-risk Patients
A prospective, single-arm, open-label study evaluating the impact of Syntrillo's telehealth program on stroke risk factors, particularly blood pressure, among 68 high-risk patients. The 6-month intervention includes personalized remote care with blood pressure monitoring, wearable tracking, and multidisciplinary telehealth visits.
Details
| Lead sponsor | Syntrillo, Inc |
|---|---|
| Phase | NA |
| Status | NOT_YET_RECRUITING |
| Enrolment | 68 |
| Start date | 2025-08 |
| Completion | 2026-05 |
Conditions
- Hypertension
- Hypertension (HTN)
- Stroke Prevention
- Cardiovascular Risk Factor
Interventions
- Technology-enabled Telehealth Care Plan
- Blood Pressure Monitoring Device
- Tenovi Smart Pillbox
- Wearable Activity Trackers (Fitbit or Apple Watch)
- Healthie EHR
- Secure Messaging Platforms (TigerConnect, Weave, AirCall)
- Antihypertensive Medication Management
- Statin Medication Management
- Antiplatelet or Anticoagulant Therapy
- Laboratory Blood Test Collection
Primary outcomes
- Change in Systolic Blood Pressure — Baseline to 6 months
This measure evaluates the average change in systolic blood pressure (SBP), which is the pressure in the arteries when the heart beats. Blood pressure is measured by participants at home using a Tenovi FDA-cleared digital blood pressure monitor. Baseline SBP is calculated using the first 10 valid readings taken during the initial week of monitoring. The 6-month value is calculated from the last 10 valid readings taken in the final week of the intervention. The study aims to observe a reduction of at least 10 mmHg in average SBP over the intervention period.